Adenosine triphosphate loading thallium-201 myocardial scintigraphy: optimal dose and diagnostic accuracy
Yonezawa, Y.; Yoshikawa, J.; Shakudo, M.; Okumachi, F.; Shiratori, K.; Koizumi, K.; Akasaka, T.; Yoshida, K.; Ikekubo, K.
Journal of Cardiology 25(1): 9-13
1995
ISSN/ISBN: 0914-5087 PMID: 7877104 Document Number: 451395
Adenosine triphosphate (ATP) is an alternative to dipyridamole or adenosine in thallium-201 myocardial scintigraphy. However, the optimal dose of ATP has not been determined. A Doppler guide wire study showed the coronary flow velocity at a dose of 0.15 mg/kg of ATP was equal or higher than that at 0.14 mg/kg of adenosine or 0.56 mg/kg of dipyridamole. ATP was given intravenously to 67 patients with coronary artery disease at 0.15 mg/kg/min for 6 min. Thallium-201 was injected at 3 min, followed by immediate and delayed (3 hrs) tomographic imaging. There was no serious side effect during examination, although chest pain (26%), dyspnea (17%), and flushing (33%) were common. The sensitivity and specificity to detect coronary artery disease were 98 and 100%, respectively. The sensitivity to detect left anterior descending artery, left circumflex artery, and right coronary artery lesions was 94, 59 and 77%, respectively. ATP loading thallium-201 scintigraphy provides an accurate diagnosis of coronary artery disease. The optimal dose of ATP is 0.15 mg/kg/min for 6 min.